Kimberly Dobbins

Kimberly Dobbins has a strong background in medical sales and territory management. Kimberly started their career in 2005 as a District Sales Manager at FoxHollow Technologies, where they successfully sold a disruptive atherectomy device for Peripheral Vascular disease. Kimberly later worked at Medtronic-Formally ATS Medical as a Territory Manager, responsible for sales of surgical heart valves and RF ablation devices. Kimberly conducted product evaluations, leading to multiple hospital conversions and played a vital role in the launch of the 3F tissue valve.

In 2009, Dobbins joined Covidien (Medtronic Minimally Invasive Therapies Group) as a Territory Manager, focusing on revenue growth of their full line of Peripheral Vascular products. Kimberly consistently exceeded sales goals and led the country in Atherectomy sales.

From 2013 to 2014, they worked at Johnson & Johnson - Codman Neurovascular as a Territory Manager, selling Neurovascular coils and Embolic devices. Kimberly established multiple training centers and provided clinical support within their region.

Dobbins then joined Cardiva Medical in 2015 as a Sr. Territory Manager. Kimberly was responsible for sales and market development of a new vascular closure device and achieved the #3 rank in the country.

In 2018, they joined AngioDynamics - Oncology as a Territory Manager, selling a portfolio of Oncology products used for liver, lung, and pancreatic procedures. Kimberly sold both capital and disposables and targeted the OR/Surgery, Interventional Radiology, and C-Suite.

Dobbins continued their career at Teleflex in 2020 as a Territory Manager, focusing on revenue growth of the QuikClot line of bleeding control devices. Kimberly called on Cardiovascular, Thoracic, Oncology, and Emergency Medicine specialties.

Currently, Dobbins is working at Biocept, Inc. as a Market Development Manager, responsible for clinical market development. The company specializes in liquid biopsy testing services that detect and monitor cancer biomarkers. Their test menu focuses on clinically actionable cancer biomarkers.

Throughout their career, Dobbins has consistently demonstrated strong sales skills, market development expertise, and a deep understanding of the medical field.

Kimberly Dobbins holds a Bachelor of Arts (B.A.) degree in Liberal Arts and Sciences, General Studies and Humanities from Penn State University. No specific information regarding the start or end year of their education at this institution is provided.